company

VESTLAND PHARMA AS

6823 SANDANE

Return on Equity
−155,7 %
Current Ratio
0,75
Debt-to-Equity Ratio
2,39
Key figures (NOK)2022
Revenue0
Net Income−123 000
Total Assets296 000
Total Equity79 000
Income (NOK)2022
Revenue0
Expenditure87 000
Operating Profit−87 000
Financial Income0
Financial Costs17 000
Financial Balance−17 000
Earnings Before Tax−104 000
Tax19 000
Net Income−123 000
Balance (NOK)2022
Total Fixed Assets275 000
Total Current Assets21 000
Total Assets296 000
Total Retained Equity−183 000
Total Equity79 000
Total Long-Term Debt189 000
Total Current Debt28 000
Total Equity and Debt296 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure87 000
Operating Profit−87 000
Financial Income0
Financial Costs17 000
Financial Balance−17 000
Dividends0
Net Income−123 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets275 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets275 000
Stock0
Total Investments0
Cash, Bank21 000
Total Current Assets21 000
Total Assets296 000
Total Equity79 000
Short-Term Group Debt0
Total Long-Term Debt189 000
Creditors28 000
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt28 000
Total Equity and Debt296 000
Financial indicators2022
Return on Equity−155,7 %
Debt-to-Equity Ratio2,39
Operating Profit Margin-
Current Ratio0,75
Quick Ratio0,75
Equity Ratio0,27
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English